Similar articles

• FDA boxed warnings: how to prescribe drugs safely.

  O'Connor NR. O'Connor NR. Am Fam Physician. 2010 Feb 1;81(3):298-303. Am Fam Physician. 2010. PMID: 20112888 Review.
• Consumer understanding of prescription drug information: an illustration using an antidepressant medication.

  Shiffman S, Gerlach KK, Sembower MA, Rohay JM. Shiffman S, et al. Ann Pharmacother. 2011 Apr;45(4):452-8. doi: 10.1345/aph.1P477. Epub 2011 Mar 22. Ann Pharmacother. 2011. PMID: 21427296
• Boxed warnings and other FDA communication tools.

  Marks NS, Weiss K. Marks NS, et al. Am Fam Physician. 2010 Feb 1;81(3):259. Am Fam Physician. 2010. PMID: 20112882 No abstract available.
• Access to safety data--stockholders versus prescribers.

  Pfeffer MA, Bowler MB. Pfeffer MA, et al. N Engl J Med. 2011 Jul 7;365(1):1-3. doi: 10.1056/NEJMp1104699. Epub 2011 Jun 29. N Engl J Med. 2011. PMID: 21714642 No abstract available.
• The significance of mitochondrial toxicity testing in drug development.

  Dykens JA, Will Y. Dykens JA, et al. Drug Discov Today. 2007 Sep;12(17-18):777-85. doi: 10.1016/j.drudis.2007.07.013. Epub 2007 Aug 22. Drug Discov Today. 2007. PMID: 17826691 Review.